News & Press Releases

Possible connection between exposure to endocrine disruptors and COVID-19 severity
November 23, 2020
> News & Press Releases

NEW ARTICLES : New press articles have been posted on the link between ED’s exposure and COVID-19 severity Inserm press article “Rôle possible de l’exposition aux perturbateurs endocriniens dans la sévérité de la Covid-19” Univeristy of Rhode Islan article “New research examines suspected links between PFAS exposure and COVID-19” Inserm article (FR) University of Rhode Island Read the full article…

OBERON press release
14 April 2019
> News & Press Releases

Coordinated by Inserm, the European project OBERON aims to develop panels of tests that will – eventually – make it possible to determine with more accuracy and certitude how compounds suspected of being endocrine disruptors might induce metabolic disorders and, ultimately, to identify these compounds.

EURION Cluster Launch Event
1st January 2019
> News & Press Releases

Joint Launch Event of Projects from the Call ‘New Testing and Screening Methods to Identify Endocrine Disrupting Chemicals’ The current testing tools, including regulatory in vivo tests and novel in vitro assays, do not appropriately identify effects related to certain less studied endocrine-mediated pathways or health outcomes, in which endocrine disruptors may be implicated. The focus of proposals should Read the full article…

© OBERON 2019, Website Created by FMOSys